T Lymphoblastic Leukemia/Lymphoma Clinical Trials

11 clinical trials for T Lymphoblastic Leukemia/Lymphoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Venetoclax and Decitabine in R/R T-ALL — RECRUITING · PHASE2
• SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies — RECRUITING · PHASE1
• uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies — RECRUITING · PHASE1
• CD7 CAR-T Cells in T-cell Lymphoma/Leukemia — RECRUITING · NA
• Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas — COMPLETED · PHASE2
• Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL. — NOT_YET_RECRUITING · PHASE2
• Romidepsin Maintenance After Allogeneic Stem Cell Transplantation — COMPLETED · PHASE1
• Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies — COMPLETED · PHASE1
• Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia — OTHER · PHASE1
• CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study — OTHER · PHASE1
• Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma — COMPLETED · NA

Refine this search